Briacell Therapeutics Corp. (BCTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.32+$0.0350 (+0.82%) on the dayAs of the close; data may be delayed.
BCTX price, last 12 months
Key stats
- Previous close
- $4.28
- Open
- $4.34
- Day range
- $4.17 – $4.37
- 52-week range
- $2.60 – $14.68
- Volume
- 140K
- Avg volume (20 days)
- 153.7K
- Market cap
- $37.5M
Performance
1W+2.5%
1M+7.1%
3M+41.0%
6M+10.9%
YTD−39.3%
1Y−58.4%
vs S&P 500, 1Y−75.1 pts
Technicals and fundamentals
About Briacell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $37.5M